Literature DB >> 1826112

Spironolactone in dermatologic therapy.

J C Shaw1.   

Abstract

In the treatment of androgen-mediated skin disorders spironolactone provides a valuable therapeutic option. This article reviews the use of spironolactone as an antiandrogen in dermatologic therapy. The endocrinologic effects, pharmacology, dermatologic uses, and side effects are discussed, and guidelines for its use are provided.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1826112     DOI： 10.1016/0190-9622(91)70034-y

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  8 in total

1.  Hormonal treatment of acne in women.

Authors:  Tobechi L Ebede; Emily L Arch; Diane Berson
Journal:  J Clin Aesthet Dermatol       Date:  2009-12

Review 2.  Hirsutism: evaluation and management.

Authors:  R E Watson; R Bouknight; P C Alguire
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

3.  Breast cancer and spironolactone: an observational postmarketing study.

Authors:  Pierre Sabatier; Jacques Amar; François Montastruc; Vanessa Rousseau; Leila Chebane; Béatrice Bouhanick; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2019-08-15       Impact factor: 2.953

4.  Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience.

Authors:  Grace K Kim; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

5.  Hirsutism: evaluation and treatment.

Authors:  Silonie Sachdeva
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

Review 6.  Transdermal penetration of topical drugs used in the treatment of acne.

Authors:  Andrea Krautheim; Harald Gollnick
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 7.  Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

Authors:  Alison M Layton; E Anne Eady; Heather Whitehouse; James Q Del Rosso; Zbys Fedorowicz; Esther J van Zuuren
Journal:  Am J Clin Dermatol       Date:  2017-04       Impact factor: 7.403

8.  Consensus Statement on the Use of Oral Contraceptive Pills in Polycystic Ovarian Syndrome Women in India.

Authors:  Duru Shah; Madhuri Patil
Journal:  J Hum Reprod Sci       Date:  2018 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.